Functional Medicine Topics: Hormones

+ What you will learn at the Hormone conference

Apply interventions that can improve both hormone and autonomic balance.
Minimize the need for hormone replacement therapy by applying treatments that improve hormone function, including dietary, lifestyle, and mind-body interventions.
Identify and address the underlying causes of imbalances in all endocrine organs.
Choose and use reliable biomarkers to assess hormone function.
Systematically evaluate hormone dysfunction with greater precision and personalization.
Prescribe bioidentical hormone therapy that is personalized and minimizes risks.
Apply a personalized, precision approach to breast cancer prevention.
Identify adrenal dysfunction and apply personalized, precision therapeutic strategies.
Use an expanded panel of biomarkers to identify thyroid dysfunction even when TSH is normal.
Identify and address subtle indicators of testosterone deficiency and female hormone imbalances.

+ Exhibit & Sponsorship Opportunities

We’re thrilled to offer you a chance to engage with a global community of practitioners dedicated to advancing evidence-based functional medicine. By sponsoring a Core Program, you’ll have prime visibility to showcase your brand, products, and services while building meaningful connections with a diverse and influential audience.

Fill out the form below, and a member of our team will connect with you to provide detailed information on sponsorship opportunities, helping you discover how your brand can make a lasting impact at an IFM Core Program.

Submit an interest form >

Re-establishing Hormonal Balance

The hypothalamic, pituitary, adrenal, thyroid, and gonadal axis modulates health in a wide variety of ways. Hormone replacement therapy (HRT) is an extremely common intervention, but it has its own health risks and may not address underlying causes of hormonal imbalance. The functional medicine approach often starts with personalized lifestyle interventions, sometimes augmented with botanicals or supplements. Explore more below about how functional medicine addresses common issues related to hormone dysfunction.

References
1.Wyne KL, Nair L, Schneiderman CP, et al. Hypothyroidism prevalence in the United States: a retrospective study combining National Health and Nutrition Examination Survey and claims data, 2009-2019. J Endocr Soc. 2022;7(1):bvac172. doi:10.1210/jendso/bvac172

2. Hu X, Chen Y, Shen Y, Tian R, Sheng Y, Que H. Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: a systematic review and meta-analysis. Front Public Health. 2022;10:1020709. doi:10.3389/fpubh.2022.1020709

3. Lou Z, Huang Y, Li S, et al. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study. BMC Public Health. 2023;23(1):916. doi:10.1186/s12889-023-15765-x

5. Zhang W, Cao G, Wu F, et al. Global burden of prostate cancer and association with socioeconomic status, 1990-2019: a systematic analysis from the Global Burden of Disease Study. J Epidemiol Glob Health. 2023;13(3):407-421. doi:10.1007/s44197-023-00103-6

6. Moradi Y, Shams-Beyranvand M, Khateri S, et al. A systematic review on the prevalence of endometriosis in women. Indian J Med Res. 2021;154(3):446-454. doi:10.4103/ijmr.IJMR_817_18

References
3. Lee SY, Pearce EN. Hyperthyroidism: a review. JAMA. 2023;330(15):1472-1483. doi:10.1001/jama.2023.19052

4. Lou Z, Huang Y, Li S, et al. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study. BMC Public Health. 2023;23(1):916. doi:10.1186/s12889-023-15765-x

7. Oguz A, Sahin M, Ulgen C, Uyan M, Gul K. Overt hypogonadism is a cardiovascular risk factor in type 2 diabetic males: an observational study. Andrologia. 2022;54(1):e14271. doi:10.1111/and.14271

8. Grossmann M, Ng Tang Fui M, Cheung AS. Late-onset hypogonadism: metabolic impact. Andrology. 2020;8(6):1519-1529. doi:10.1111/andr.12705

9. Patel P, Shiff B, Kohn TP, Ramasamy R. Impaired sleep is associated with low testosterone in US adult males: results from the National Health and Nutrition Examination Survey. World J Urol. 2019;37(7):1449-1453. doi:10.1007/s00345-018-2485-2

10. Tančić-Gajić M, Vukčević M, Ivović M, et al. Obstructive sleep apnea is associated with low testosterone levels in severely obese men. Front Endocrinol (Lausanne). 2021;12:622496. doi:10.3389/fendo.2021.622496